Capivasertib 17228-9501
Product NDC
17228-9501- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- November 10, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Capivasertib | 200 mg/1 |
Packaging Options(1)
15000 TABLET, FILM COATED in 1 BAG (17228-9501-3)